RSS-Feed abonnieren

DOI: 10.1055/a-2772-5837
Characterization of Arteriovenous Thrombus Formation and Propagation in a Mouse Arteriovenous Fistula Model
Autor*innen
Funding Information This work was supported by the US National Institutes of Health grants R01-HL 162580 (to A.D.) and R01-HL144476 (to A.D.). Bryan B. Ho was funded by the US National Institutes of Health T32 training grant 2T32GM086287–16.

Abstract
Background
Compared with an arterial thrombus (AT) or a venous thrombus (VT), there is limited knowledge about arteriovenous thrombus (AVT). AVT develops in 69% of arteriovenous fistulae (AVF) and 50% of arteriovenous grafts (AVG) within 1 year. Thrombosis remains one of the major complications after creation of a vascular access often resulting in failure of the access.
Objective
To characterize and differentiate AVT from VT or AT.
Methods
An AVT model was established by a needle puncture through the aorta to the inferior vena cava (IVC) in wild type mice and different reporter mice and compared with a mouse venous thrombus (VT) model using IVC ligation. AVT was also examined under defined arteriovenous flow conditions. AVT was examined by gross view, histology, immunofluorescence, and scanning electron microscopy.
Results
AVT occurs immediately at the juxta-anastomotic area (JAA) after successful arteriovenous flow was established, with platelets being a major component of early AVT. Reduced injury to the endothelium resulted in smaller AVT, whereas local delivery of rapamycin to inhibit cell proliferation failed to decrease the volume of the AVT. Incomplete reendothelialization of the peri-fistula exit area correlated with growth of the AVT. AVT universally presents at the JAA in other arteriovenous models.
Conclusion
We provide the first detailed histopathological characterization of AVT induced by AVF. AVT originates from the injured vessel wall and is more similar to AT than VT. This model provides a valuable tool to characterize AVT. Both this AVT model and our data have potential for clinical translation.
Keywords
arteriovenous thrombus - arteriovenous flow - neointimal hyperplasia - juxta-anastomosis stenosisData Availability Statement
The authors confirm that the data supporting the results of this study are available in the article. If required, further information can be obtained on request from the corresponding author Dr. Alan Dardik (alan.dardik@mountsinai.org). The authors will share more detailed information about any of the animal models or analytical procedures with anyone who wishes to use these models or procedures in their research.
‡ These authors contributed equally to this article.
Publikationsverlauf
Eingereicht: 25. September 2025
Angenommen nach Revision: 14. Dezember 2025
Accepted Manuscript online:
16. Dezember 2025
Artikel online veröffentlicht:
31. Dezember 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Alkarithi G, Duval C, Shi Y, Macrae FL, Ariëns RAS. Thrombus structural composition in cardiovascular disease. Arterioscler Thromb Vasc Biol 2021; 41 (09) 2370-2383
- 2 Undas A, Ariëns RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol 2011; 31 (12) e88-e99
- 3 Kattula S, Byrnes JR, Wolberg AS. Fibrinogen and fibrin in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2017; 37 (03) e13-e21
- 4 Korn A, Alipour H, Zane J. et al. Factors associated with early thrombosis after arteriovenous fistula creation. Ann Vasc Surg 2018; 49: 281-284
- 5 Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2001; 34 (04) 694-700
- 6 Kanterman RY, Vesely TM, Pilgram TK, Guy BW, Windus DW, Picus D. Dialysis access grafts: anatomic location of venous stenosis and results of angioplasty. Radiology 1995; 195 (01) 135-139
- 7 Singh D, Harita C. A tribute to the inventor of arteriovenous fistula for hemodialysis: James E Cimino. Indian J Vasc Endovasc Surg 2019; 6(2): 127-128
- 8 Lok CE, Huber TS, Orchanian-Cheff A, Rajan DK. Arteriovenous access for hemodialysis: a review. JAMA 2024; 331 (15) 1307-1317
- 9 Li Y, Hu K, Li Y, Lu C, Guo Y, Wang W. The rodent models of arteriovenous fistula. Front Cardiovasc Med 2024; 11: 1293568
- 10 Liu S, Wang T, Wang J. et al. Reduced patency in left-sided arteriovenous grafts in a porcine model. J Vasc Surg 2020; 72 (01) 305-317.e6
- 11 Bai H, Dardik A, Xing Y. Decellularized carotid artery functions as an arteriovenous graft. J Surg Res 2019; 234: 33-39
- 12 Eikelboom JW, Connolly SJ, Bosch J. et al; COMPASS Investigators. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 2017; 377 (14) 1319-1330
- 13 Stevens SM, Woller SC, Kreuziger LB. et al. Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and expert panel report. Chest 2021; 160 (06) e545-e608
- 14 Lok CE, Huber TS, Lee T. et al; National Kidney Foundation. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis 2020; 75 (4, Suppl 2): S1-S164
- 15 Hanasono MM, Butler CE. Prevention and treatment of thrombosis in microvascular surgery. J Reconstr Microsurg 2008; 24 (05) 305-314
- 16 Azuma T, Fukushima T. Disturbance of blood flow as a factor of thrombus formation. Thromb Res 1976; 8 (2, suppl): 375-380
- 17 Ene-Iordache B, Semperboni C, Dubini G, Remuzzi A. Disturbed flow in a patient-specific arteriovenous fistula for hemodialysis: multidirectional and reciprocating near-wall flow patterns. J Biomech 2015; 48 (10) 2195-2200
- 18 Bai H, Varsanik MA, Thaxton C. et al. Disturbed flow in the juxta-anastomotic area of an arteriovenous fistula correlates with endothelial loss, acute thrombus formation, and neointimal hyperplasia. Am J Physiol Heart Circ Physiol 2024; 326 (06) H1446-H1461
- 19 Bai H, Sadaghianloo N, Gorecka J. et al. Artery to vein configuration of arteriovenous fistula improves hemodynamics to increase maturation and patency. Sci Transl Med 2020; 12 (557) eaax7613
- 20 Zeng Z, Xia L, Fan X. et al. Platelet-derived miR-223 promotes a phenotypic switch in arterial injury repair. J Clin Invest 2019; 129 (03) 1372-1386
- 21 Bai H, Wei S, Xie B. et al. Endothelial nitric oxide synthase (eNOS) mediates neointimal thickness in arteriovenous fistulae with different anastomotic angles in rats. J Vasc Access 2022; 23 (03) 403-411
- 22 Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9 (07) 671-675
- 23 Bai H, Li Z, Zhang W. et al. Early thrombus formation is required for eccentric and heterogeneous neointimal hyperplasia under disturbed flow. J Thromb Haemost 2024; 22 (12) 3614-3628
- 24 Diaz JA, Obi AT, Myers Jr DD. et al. Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol 2012; 32 (03) 556-562
- 25 Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet 2021; 398 (10294): 64-77
- 26 Torsney E, Mayr U, Zou Y, Thompson WD, Hu Y, Xu Q. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. Circ Res 2004; 94 (11) 1466-1473
- 27 Richter GM, Palmaz JC, Noeldge G, Tio F. Relationship between blood flow, thrombus, and neointima in stents. J Vasc Interv Radiol 1999; 10 (05) 598-604
- 28 Diaz JA, Saha P, Cooley B. et al. Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application. J Thromb Haemost 2019; 17 (04) 699-707
- 29 Bai H, Sun P, Wu H. et al. The application of tissue-engineered fish swim bladder vascular graft. Commun Biol 2021; 4 (01) 1153
- 30 Bai H, Wu H, Zhang L. et al. Adventitial injection of HA/SA hydrogel loaded with PLGA rapamycin nanoparticle inhibits neointimal hyperplasia in a rat aortic wire injury model. Drug Deliv Transl Res 2022; 12 (12) 2950-2959
- 31 Barcena AJR, Perez JVD, Bernardino MR. et al. Controlled delivery of rosuvastatin or rapamycin through electrospun bismuth nanoparticle-infused perivascular wraps promotes arteriovenous fistula maturation. ACS Appl Mater Interfaces 2024; 16 (26) 33159-33168
- 32 Lookstein RA, Haruguchi H, Ouriel K. et al; IN.PACT AV Access Investigators. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med 2020; 383 (08) 733-742
- 33 Karunanithy N, Robinson EJ, Ahmad F. et al. A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulas. Kidney Int 2021; 100 (02) 447-456
- 34 Chernysh IN, Nagaswami C, Kosolapova S. et al. The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli. Sci Rep 2020; 10 (01) 5112
- 35 Yamamoto K, Protack CD, Kuwahara G. et al. Disturbed shear stress reduces Klf2 expression in arterial-venous fistulae in vivo. Physiol Rep 2015; 3 (03) e12348
- 36 Quencer KB, Oklu R. Hemodialysis access thrombosis. Cardiovasc Diagn Ther 2017; 7 (Suppl. 03) S299-S308
- 37 Chang CJ, Ko YS, Ko PJ. et al. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int 2005; 68 (03) 1312-1319
- 38 Roy-Chaudhury P, Arend L, Zhang J. et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis 2007; 50 (05) 782-790